Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6G9A

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-X
Temperature [K]100
Detector technologyPIXEL
Collection date2015-02-10
DetectorDECTRIS PILATUS 300K
Wavelength(s)1.54178
Spacegroup nameP 1 21 1
Unit cell lengths48.919, 70.291, 60.928
Unit cell angles90.00, 110.87, 90.00
Refinement procedure
Resolution45.710 - 1.910
R-factor0.182
Rwork0.178
R-free0.25000
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.013
RMSD bond angle1.110
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]45.7101.960
High resolution limit [Å]1.9101.910
Rmeas0.0881.383
Number of reflections299832346
<I/σ(I)>9
Completeness [%]99.498.9
Redundancy2.8
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22930.3M (NH4)2SO4, 32.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol

223532

PDB entries from 2024-08-07

PDB statisticsPDBj update infoContact PDBjnumon